Patients with high-risk acute myocardial infarction randomized to one of two treatment strategies: delay and eligibility questions

Grines et al. [(1)][1]reported randomization of patients with high-risk acute myocardial infarction (AMI) to one of two treatment strategies, namely transfer for primary percutaneous transluminal coronary angioplasty (PTCA) or on-site thrombolysis. Randomization required a mean of 44 min (median 32